Alberto Conca, CIO at Swiss wealth manager LFG+ZEST, has been adding exposure to pharma, biotech and medtech in recent weeks, drawn by strong cash-flow yields and the prospect of U.S. rate cuts ...

The French biotech is developing a new drug approach in a disease market that’s projected to grow to $30 billion by 2030.

The action will remove from use the very few flu shots that contain the contested preservative, elevating unproven fears it ...